Teva Posts $452 Million Loss for Second Quarter

Settlement of patent infringement lawsuit with Pfizer drags down what was an otherwise profitable quarter with company revenue of $4.92 billion falling just shy of analysts' forecasts.

comments Print
Teva Pharmaceuticals declared a $452 million loss for the second quarter of 2013 due to $1.6 billion compensation the company must pay Pfizer for patent infringement in its quarterly earnings report issued...